# Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis

> **NCT02576249** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 29 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Normal saline
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT02576249
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-10
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576249, "Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02576249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*